| Company/Division name | Fujifilm Diosynth Biotechnologies |
| Parent company | Fujifilm Corporation |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2019 |
| Capital investment ($): | 90 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Morrisville |
| State(s) reshored to: | NC |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell cultures and microbial products |
| What domestic positive factors made reshoring more attractive? | Customer responsiveness improvement, Eco-system synergies, Proximity to customers/market |
